Online Radical Acceptance program for social anxiety

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will assign 100 adults with Social Anxiety Disorder to either a self-guided Radical Acceptance program or an active relaxation-skills program, both delivered online. After diagnostic confirmation, participants complete a baseline learning session and six brief home practice sessions over two weeks, with culturally adapted video training and brief debriefs. Outcomes include repeated symptom surveys and brief computer behavioral tasks to measure mechanisms such as interpretation bias and emotion-regulation flexibility, with follow-ups a few weeks and a few months later. All procedures are conducted remotely and compare changes over time between the two interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 18-45
* Score \> 9 on Mini-SPIN
* Positive responses in brief phone screening
* Eligibility confirmed in Zoom interview using ADIS
* Native Hebrew speakers
* Having regular access to a computer.

Exclusion Criteria:

* Changes in psychiatric medication in the past 3 months
* Current or past diagnosis of bipolar disorder
* Current or past diagnosis of schizophrenia
* Current or past diagnosis of PTSD
* Current or past diagnosis of substance use disorder
* History of traumatic brain injury (TBI)
* Previous experience with Dialectical Behavior Therapy (DBT)
* Currently receiving psychotherapy specifically targeting social anxiety

Where it's running

• University of Haifa
  Haifa, Israel Recruiting

Study contacts

• Principal investigator: Noam Weinbach, PhD — School of Psychological Sciences, University of Haifa
• Study coordinator: Noam Weinbach, PhD
• Email: nweinbach@psy.haifa.ac.il
• Phone: +972542249161

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Caplyta versus placebo for adults with social anxiety disorder

  This study tests whether Caplyta works better than a placebo for adults with social anxiety disorder over 8 weeks.

  Recruiting Phase 4 IMA Clinical Research · New York, New York · NCT07799493

• Expectancy Focused Exposure for Anxiety Disorders

  We test whether Expectancy Focused Exposure helps reduce anxiety symptoms and prevent fear from coming back better than Anxiety Focused Exposure in adults with anxiety disorders.

  Recruiting University of Chile · Santiago, Santiago Metropolitan · NCT07753330

• Attention Bias Modification for Social Anxiety Disorder: Does training help, or is it a placebo effect?

  This study tests whether a computerized attention training (ABM) reduces social anxiety symptoms in adults with SAD, and whether any improvement comes from actual attentional changes or from placebo/expectancy factors.

  Recruiting Tel Aviv University · Tel Aviv · NCT07666776

• Short bursts of noninvasive brain stimulation to the prefrontal cortex for social anxiety

  This treatment will test whether daily intermittent theta-burst brain stimulation to the prefrontal cortex can reduce social anxiety symptoms in people with SAD while tracking brain changes with EEG.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07466277

• ACTsocially: Using Acceptance and Commitment Therapy to help teens with social anxiety and oppositional behavior

  This project will test whether a transdiagnostic Acceptance and Commitment Therapy (ACT) program can reduce social anxiety and oppositional defiant behaviors in adolescents who have both conditions.

  Recruiting University of Coimbra · Coimbra · NCT07456631

• NTX-1472 for adults with social anxiety disorder

  This study will test whether the drug NTX-1472 is safe and helps reduce symptoms in adults with generalized social anxiety disorder.

  Recruiting at 10 sites Phase 2 Newleos Therapeutics, Inc. · Encino, California and 10 other locations · NCT07323784

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.